why choose us

First received: March 23, 2023

Clinical Trial: A First-In-Human Trial of pTTL in Advanced Colorectal Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Colorectal Cancer

Study Type: INTERVENTIONAL


Official Title: A First-In-Human, Phase I/IIa Trial of the Novel T Cell Immunotherapy pTTL in Patients With Advanced Colorectal Cancer

Brief Summary: This is an open-label, non-randomised FIH trial investigating the safety and tolerability of a novel ATMP, pTTL, composed of autologous tumour-draining lymph node-derived T cells stimulated in vitro with personalised cancer neoantigens.The neoantigens are selected through a process starting with next generation sequencing (NGS) of tumour material from the patient followed by selection of neoantigenic mutations using an in-house software, PIOR®.Selected neoantigen epitopes are expressed as recombinant proteins,…

Read more